In this review:
Pre-existing antibodies to anti-TNFs
Anti-TNF therapy and cardiovascular disease in IBD
Utility of infection screening in IBD
Faecal microbiota transplantation:
• Immunological effects
• Clinical effects in refractory pouchitis
• Microbiotal and clinical effects in UC
When to stop therapy in CD?
Experimental benefit of metformin in colitis
Vitamin D status:
• In CD patients vs. healthy controls
• Plus bone mineral density in CD
• Plus bone mineral density in UC
• Vs. disease severity in IBD
Faecal incontinence: underreported and under-recognised
Anaemia and its treatment:
IBD patient perceptions
Infliximab re-treatment after anti-TNF failure
Elective withdrawal of anti-TNF therapy
Please login below to download this issue (PDF)